rs2735940

This is a upstream gene variant variant in the TERT gene.

GWAS Catalog Trait Associations (3)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

colorectal cancer

Allele G
OR 0.08
p 6.0e-36
N 254,791
Large GWAS
multi-ancestry
Allele G
OR
β 0.092
p 9.0e-29
N 839,703
Large GWAS
multi-ancestry
Allele G
OR 1.08
p 1.0e-11
N 92,967
Large GWAS
European
Schmit SL et al. Novel Common Genetic Susceptibility Loci for Colorectal Cancer. Journal of the National Cancer Institute 111(2):146-157 (2019)
Allele G
OR 1.09
p 3.0e-13
N 67,812
Large GWAS
multi-ancestry

colorectal cancer, colorectal adenoma

Allele G
OR 1.09
p 5.0e-25
N 125,478
Large GWAS
multi-ancestry

solar lentigines measurement

Allele A
OR 0.33
p 1.0e-16
N 1,137
Large GWAS
European

ClinVar annotation

Association
2 submitters1 publication

Chronic osteomyelitis; Coronary artery disease, susceptibility to

View on ClinVar →

Research that mentions this SNP (4)

Telomere structure and maintenance gene variants and risk of five cancer types
Meta-analysisN=136,308Sara Karami et al.(2016)· International Journal of Cancer

Meta-analysis of 204,993 SNPs in 22 telomere structure and maintenance genes identified 13 independent SNPs associated with colorectal, breast, prostate, ovarian, and lung cancer risk in 61,851 cases and 74,457 controls of European descent. Seven of these associations were novel findings. Notable findings include rs12655062 (positively associated with prostate cancer, inversely with colorectal/ovarian cancers), rs75316749 (positively associated with colorectal, breast, ovarian, and lung cancers), rs974404 and rs12144215 in DCLRE1B (inversely associated with prostate/lung and colorectal/breast/ovarian cancers respectively), rs34978822 in RTEL1 (inversely associated with prostate/lung cancers), and rs116895242 near POT1 (inversely associated with colorectal, ovarian, and lung cancers).

Traits studied:Aggressive prostate cancerBladder cancerBreast cancerChronic lymphatic leukemiaChronic lymphocytic leukemiaColorectal cancerEndometrial cancerEndometrioid ovarian cancerEsophageal cancerEstrogen receptor negative breast cancerGastric cancerGlioblastomaGliomaGraves diseaseHigh-grade gliomaLung adenocarcinomaLung cancerMelanomaMultiple myelomaNasopharyngeal cancerOsteosarcomaOvarian cancerPancreatic cancerProstate cancerRenal cancerRheumatoid arthritisSerous ovarian cancerSkin cancerSquamous lung cancerTesticular cancer
Telomere length, telomere‐related genes, and breast cancer risk: The breast cancer health disparities study
AssociationN=8,123Andrew J. Pellatt et al.(2013)· Genes, Chromosomes and Cancer

This case-control study of 3,754 breast cancer cases and 4,369 controls from admixed US and Mexican women examined telomere length (TL) and nine telomere-related genes. Longer TL was associated with increased breast cancer risk (OR 1.87, 95% CI 1.38-2.55), with strongest association among women with ≥70% Indigenous American ancestry (OR 3.11, 95% CI 1.74-5.67). Multiple SNPs showed associations with breast cancer risk, including TEP1 rs938886 (OR 0.82), TERT rs4246742 (OR 0.85), TERT rs2242652 (OR 1.51), TERF2 rs3785074 (OR 1.13), and TNKS rs6990300 (OR 0.89). Several SNPs showed differential associations by hormone receptor status and genetic ancestry.

Traits studied:Breast cancerBreast cancer by hormone receptor status (ER/PR)
Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk
AssociationN=396Philipp Hofer et al.(2012)· Molecular Carcinogenesis

This case-control study of 218 Egyptian breast cancer patients and 178 healthy controls examined associations between hTERT polymorphisms and breast cancer risk. The GG genotype and G allele of hTERT rs2736098G>A were significantly associated with increased breast cancer risk (OR=7.484, p≤0.001; OR=1.743, p=0.006), as was the rs2735940 TT genotype (OR=1.519, p=0.045). The MNS16A tandem repeat showed no significant association. Telomere length was significantly reduced in breast cancer patients younger than 40 years compared to age-matched controls.

Traits studied:Breast cancer
Telomere length and genetic analyses in population‐based studies of endometrial cancer risk
AssociationN=2,359Jennifer Prescott et al.(2010)· Cancer

This nested case-control study examined the association between relative telomere length and genetic variants in telomere maintenance genes (TERT, TNKS2, POT1, TERF1, TERF2) with endometrial cancer risk in 674 cases and 1,685 controls. Relative telomere length was not significantly associated with endometrial cancer risk (OR=1.20, 95% CI=0.73-1.96). However, variants rs2736122 in TERT (OR=1.18, 95% CI=1.01-1.38) and rs12412538 in TNKS2 (OR=1.16, 95% CI=1.00-1.34) showed elevated endometrial cancer risk, though these associations did not reach statistical significance after multiple comparisons correction.

Traits studied:Endometrial cancer

About TERT

Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]

View all TERT variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…